- Home
- MTN vs CYTK Comparison
MTN vs CYTK Comparison
Compare MTN & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTN
- CYTK
- Stock Information
- Founded
- MTN 1997
- CYTK 1997
- Country
- MTN United States
- CYTK United States
- Employees
- MTN N/A
- CYTK N/A
- Industry
- MTN Services-Misc. Amusement & Recreation
- CYTK Biotechnology: Pharmaceutical Preparations
- Sector
- MTN Consumer Discretionary
- CYTK Health Care
- Exchange
- MTN Nasdaq
- CYTK Nasdaq
- Market Cap
- MTN 5.2B
- CYTK 5.6B
- IPO Year
- MTN 1997
- CYTK 2004
- Fundamental
- Price
- MTN $156.68
- CYTK $32.43
- Analyst Decision
- MTN Hold
- CYTK Buy
- Analyst Count
- MTN 10
- CYTK 14
- Target Price
- MTN $186.50
- CYTK $70.92
- AVG Volume (30 Days)
- MTN 1.0M
- CYTK 1.3M
- Earning Date
- MTN 06-05-2025
- CYTK 08-07-2025
- Dividend Yield
- MTN 5.68%
- CYTK N/A
- EPS Growth
- MTN 6.60
- CYTK N/A
- EPS
- MTN 7.74
- CYTK N/A
- Revenue
- MTN $2,958,444,000.00
- CYTK $19,218,000.00
- Revenue This Year
- MTN $3.77
- CYTK $18.02
- Revenue Next Year
- MTN $3.71
- CYTK $737.32
- P/E Ratio
- MTN $20.20
- CYTK N/A
- Revenue Growth
- MTN 2.38
- CYTK 412.21
- 52 Week Low
- MTN $129.85
- CYTK $29.31
- 52 Week High
- MTN $199.45
- CYTK $61.38
- Technical
- Relative Strength Index (RSI)
- MTN 55.93
- CYTK 46.32
- Support Level
- MTN $147.53
- CYTK $32.02
- Resistance Level
- MTN $160.70
- CYTK $34.72
- Average True Range (ATR)
- MTN 4.56
- CYTK 1.30
- MACD
- MTN -0.22
- CYTK 0.26
- Stochastic Oscillator
- MTN 69.48
- CYTK 45.08
About MTN Vail Resorts Inc.
Vail Resorts Inc Bhd is a resorts and casinos company that operates mountain resorts and ski areas. The company has three business segments that include Mountain, Lodging, and Real Estate. The Mountain segment operates numerous ski resort properties that offer a variety of winter and summer activities, such as skiing, snowboarding, snowshoeing, hiking, and mountain biking. The Lodging segment owns and operates hotels and condominiums. The Real Estate segment owns, develops, and leases real estate, typically near its other properties. The company generates the vast majority of its revenue within the United States.
About CYTK Cytokinetics Incorporated
Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.